tegaserod: Clinical Trials

3 completed, 2 terminated, 1 withdrawn. 6 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	6	Completed 3, Terminated 2, Withdrawn 1

Follow tegaserod: new trials by email Literature Review of tegaserod trials Research Report on tegaserod

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis Tegaserod - Gastroparesis, Diabetes	Phase 4	Terminated	Novartis	40	2007-01-01	2012-05-04
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients Tegaserod - Chronic Constipation	Phase 4	Terminated	Novartis	60	2006-07-01	2016-03-04
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation Tegaserod and Polyethylene Glycol 3350 - Constipation	Phase 4	Completed	Novartis	52	2005-05-01	2016-03-03
Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS Tegaserod - IBS-C and IBS With Mixed Bowel Habits	Phase 4	Completed	Novartis	664	2004-04-01	2008-01-28
Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation Tegaserod - Chronic Constipation	Phase 4	Completed	Novartis	250	2004-04-01	2008-02-01
The Effects of Tegaserod vs. Placebo on Whole Gut Transit Time in Patients With Chronic Constipation and Dyspepsia Tegaserod and Placebo - Constipation and Dyspepsia	Phase 4	Withdrawn	Novartis			2016-03-04

Conditions studied

Constipation (3)  ·  Diabetes Mellitus (1)  ·  Dyspepsia (1)  ·  Gastroparesis (1)

Sponsors

Novartis (6)

Countries

United States (3)  ·  Switzerland (1)

Top investigators

Henry Parkman, MD (1)  ·  Michael Crowell, PhD (1)  ·  Nicholas Talley, MD (1)  ·  William Chey, MD (1)